US Bancorp’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.47K | Buy |
583
+108
| +23% | +$1.38K | ﹤0.01% | 3454 |
|
|
2025
Q4 | $4.27K | Sell |
475
-1,490
| -76% | -$20.5K | ﹤0.01% | 3591 |
|
|
2025
Q3 | $33.9K | Sell |
1,965
-1,151
| -37% | -$14.2K | ﹤0.01% | 2849 |
|
|
2025
Q2 | $29.2K | Buy |
3,116
+1,055
| +51% | +$8.66K | ﹤0.01% | 3023 |
|
|
2025
Q1 | $14.7K | Buy |
2,061
+416
| +25% | +$4.2K | ﹤0.01% | 3309 |
|
|
2024
Q4 | $19.2K | Buy |
1,645
+890
| +118% | +$13.9K | ﹤0.01% | 3178 |
|
|
2024
Q3 | $15.5K | Sell |
755
-140
| -16% | -$3.23K | ﹤0.01% | 3219 |
|
|
2024
Q2 | $20K | Sell |
895
-6,371
| -88% | -$152K | ﹤0.01% | 3065 |
|
|
2024
Q1 | $200K | Sell |
7,266
-1,610
| -18% | -$44.7K | ﹤0.01% | 2012 |
|
|
2023
Q4 | $271K | Buy |
8,876
+2,189
| +33% | +$62.9K | ﹤0.01% | 1849 |
|
|
2023
Q3 | $211K | Sell |
6,687
-212
| -3% | -$8.22K | ﹤0.01% | 1799 |
|
|
2023
Q2 | $281K | Sell |
6,899
-151
| -2% | -$6.12K | ﹤0.01% | 1704 |
|
|
2023
Q1 | $263K | Buy |
7,050
+585
| +9% | +$22.9K | ﹤0.01% | 1735 |
|
|
2022
Q4 | $226K | Sell |
6,465
-5,575
| -46% | -$265K | ﹤0.01% | 1801 |
|
|
2022
Q3 | $673K | Buy |
12,040
+3,345
| +38% | +$208K | ﹤0.01% | 1249 |
|
|
2022
Q2 | $449K | Sell |
8,695
-6,508
| -43% | -$330K | ﹤0.01% | 1507 |
|
|
2022
Q1 | $1.1M | Buy |
15,203
+558
| +4% | +$47.3K | ﹤0.01% | 1138 |
|
|
2021
Q4 | $1.73M | Buy |
14,645
+1,800
| +14% | +$225K | ﹤0.01% | 965 |
|
|
2021
Q3 | $1.72M | Buy |
12,845
+1,444
| +13% | +$219K | ﹤0.01% | 932 |
|
|
2021
Q2 | $1.85M | Buy |
11,401
+5,375
| +89% | +$419K | ﹤0.01% | 915 |
|
|
2021
Q1 | $484K | Buy |
6,026
+5,351
| +793% | +$359K | ﹤0.01% | 1521 |
|
|
2020
Q4 | $37K | Sell |
675
-2,300
| -77% | -$83.5K | ﹤0.01% | 2636 |
|
|
2020
Q3 | $59K | Sell |
2,975
-2,500
| -46% | -$52.1K | ﹤0.01% | 2329 |
|
|
2020
Q2 | $115K | Buy |
5,475
+2,000
| +58% | +$34K | ﹤0.01% | 2032 |
|
|
2020
Q1 | $42K | Buy |
3,475
+3,300
| +1,886% | +$44.5K | ﹤0.01% | 2432 |
|
|
2019
Q4 | $3K | Hold |
175
| – | – | ﹤0.01% | 3408 |
|
|
2019
Q3 | $2K | Hold |
175
| – | – | ﹤0.01% | 3429 |
|
|
2019
Q2 | $3K | Hold |
175
| – | – | ﹤0.01% | 3389 |
|
|
2019
Q1 | $3K | Hold |
175
| – | – | ﹤0.01% | 3355 |
|
|
2018
Q4 | $2K | Hold |
175
| – | – | ﹤0.01% | 3418 |
|
|
2018
Q3 | $5K | Buy |
+175
| New | +$5.09K | ﹤0.01% | 3320 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
